Russell Frank Company’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $12.1M | Buy |
193,043
+65,691
| +52% | +$4.12M | 0.02% | 831 |
|
|
2015
Q4 | $12M | Buy |
127,352
+97,758
| +330% | +$9.24M | 0.02% | 786 |
|
|
2015
Q3 | $2.38M | Sell |
29,594
-28,088
| -49% | -$2.26M | ﹤0.01% | 1748 |
|
|
2015
Q2 | $6.91M | Buy |
57,682
+4,846
| +9% | +$581K | 0.01% | 1224 |
|
|
2015
Q1 | $5.52M | Buy |
52,836
+7,894
| +18% | +$824K | 0.01% | 1194 |
|
|
2014
Q4 | $4.36M | Sell |
44,942
-6,900
| -13% | -$669K | 0.01% | 1371 |
|
|
2014
Q3 | $4.05M | Sell |
51,842
-43,273
| -45% | -$3.38M | 0.01% | 1411 |
|
|
2014
Q2 | $5.11M | Sell |
95,115
-39,919
| -30% | -$2.15M | 0.01% | 1309 |
|
|
2014
Q1 | $9.07M | Buy |
135,034
+83,515
| +162% | +$5.61M | 0.02% | 941 |
|
|
2013
Q4 | $4.37M | Sell |
51,519
-10,043
| -16% | -$852K | 0.01% | 1300 |
|
|
2013
Q3 | $3.94M | Buy |
61,562
+7,266
| +13% | +$465K | 0.01% | 1479 |
|
|
2013
Q2 | $1.68M | Buy |
+54,296
| New | +$1.68M | ﹤0.01% | 1854 |
|